Linked Life Data

18781849

Source:http://linkedlifedata.com/resource/pubmed/id/18781849

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
pubmed:issue
9
pubmed:dateCreated
2008-9-10
pubmed:abstractText
Sequenom is an established genomic analysis company with two principal divisions: genetic analysis systems and reagents, and noninvasive prenatal diagnostics. As an industry innovator in DNA detection technology, Sequenom's benchtop MassARRAY Compact system allows a direct mass measurement of nucleic acids, providing unparalleled precision and quantitation. The MassARRAY system is a multi-application MALDI-TOF MS platform for genotyping, methylation and quantitative gene expression analysis. Sequenom continues to refine these core applications and has developed several new applications for copy number variation analysis and comparative sequence analysis for bacteria and viruses. On the diagnostics front, Sequenom is developing a comprehensive portfolio of prenatal test methods by combining the versatility of the MassARRAY system with the Company's SEQureDxtrade mark technology, which enables the detection of circulating cell-free fetal nucleic acids in a maternal blood sample.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1744-8042
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1211-5
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Sequenom, Inc.
pubmed:affiliation
Sequenom, Inc., 3595 John Hopkins Ct., San Diego, CA 92121, USA.
pubmed:publicationType
Journal Article